(19)
(11) EP 4 322 769 A1

(12)

(43) Date of publication:
21.02.2024 Bulletin 2024/08

(21) Application number: 22788771.8

(22) Date of filing: 12.04.2022
(51) International Patent Classification (IPC): 
A23L 33/00(2016.01)
A61K 36/074(2006.01)
A61K 36/068(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 36/074; A61K 36/481; A61K 36/62; A61K 36/484; A61K 36/734; A61K 36/355; A61K 36/287; A61K 9/0014; A61K 9/0053
 
C-Sets:
  1. A61K 36/734, A61K 2300/00;
  2. A61K 36/355, A61K 2300/00;
  3. A61K 36/287, A61K 2300/00;
  4. A61K 36/481, A61K 2300/00;
  5. A61K 36/62, A61K 2300/00;
  6. A61K 36/484, A61K 2300/00;
  7. A61K 36/074, A61K 2300/00;

(86) International application number:
PCT/US2022/024425
(87) International publication number:
WO 2022/221282 (20.10.2022 Gazette 2022/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 12.04.2021 US 202163173554 P

(71) Applicants:
  • Virongy Biosciences, Inc.
    Manassas, VA 20109 (US)
  • Wu, Yuntao
    Manassas, Virginia 20112 (US)

(72) Inventor:
  • WU, Yuntao
    Manassas, VA 20112 (US)

(74) Representative: dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB 
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln
50667 Köln (DE)

   


(54) COMPOSITIONS FOR TREATING HIV INFECTIONS